Medicines Co to Discuss Results of ORION-11 Study - Conference Call

2/9/2019 8:00

שיחת ועידה Medicines Co

Medicines Co Conference call or earnings call will be held on 02/09/2019 via an 800 number (toll-free). During the earnings conference call's session Medicines Co will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact Medicines Co for this information
Schedule a teleconference with QCONF and get 5 free calls with our conference service.
We are a global biopharmaceutical company focused on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on leading acute/intensive care hospitals worldwide. We market Angiomax® (bivalirudin), Cleviprex® (clevidipine) injectable emulsion, Ionsys® (fentanyl iontophoretic transdermal system), Kengreal® (cangrelor), Minocin (minocycline) for injection, and Orbactiv® (oritavancin). We also have a pipeline of acute and intensive care hospital products in development, including ABP-700, ALN-PCSsc, Carbavance® and MDCO-216. We have the right to develop, manufacture and commercialize ALN-PCSsc under our collaboration agreement with Alnylam Pharmaceuticals, Inc., or Alnylam.    
קרא עוד שיחת ועידה

Medicines Co (MDCO)

8 Sylvan Way, Parsippany New Jersey 07054, United States